RENAISSANCE TECHNOLOGIES LLC
Position in CRVS — Corvus Pharmaceuticals, Inc.
CIK 1037389
NEW YORK, NY
Position in CRVS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,189,565
+$528,813 QoQ
Shares Held
81,310
-50.8% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,560,012 across 312 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in CRVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,189,565 | 81,310 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $660,752 | 165,188 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $842,661 | 264,988 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,090,180 | 390,688 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,041,184 | 386,588 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,026,356 | 563,932 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,133,916 | 637,032 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,033,880 | 587,432 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $615,744 | 421,743 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,121,351 | 489,673 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $460,489 | 506,032 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $551,337 | 648,632 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $798,950 | 975,519 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $953,302 | 962,932 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,477,856 | 901,132 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,515,394 | 1,043,732 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,973,550 | 614,370 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,757,046 | 658,070 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,043,487 | 663,470 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,837,569 | 797,070 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,508,750 | 875,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,806,768 | 1,031,900 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,963,777 | 930,700 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||